Soberana 02 anti-COVID-19 vaccine candidateResults from the trial of Cuba anti-COVID-19 vaccine candidate Soberana 02 are out. Its two-dose immunization scheme, after its Phase III trial, has achieved 62 percent efficacy, the manufacturer BioCubaFarma announced Saturday.

The U.S. blockade against Cuba today reaches a higher level of hostilityThe U.S. blockade against Cuba today reaches a higher level of hostility, with direct and extraterritorial actions amid the economic and health complexities imposed by the pandemic.

Minister of Economy and Planning (MEP), Alejandro Gil.Cuba is working to strengthen the socialist state enterprise and the creation of micro, small and medium-sized entities (MSMEs)to liberate productive forces and boosting the economy.

Vaccine candidates Abdala and Mambisa will be administeredA clinical trial aimed at the pediatric population and another one for convalescents are among the new researches with the anti-COVID-19 vaccine candidates Abdala and Mambisa, two of the five developed by Cuban scientists.